Clinical Trials on Healthy Chinese Subjects

Total 20769 results

Ohio State University Comprehensive Cancer Center

Active, not recruiting

Food Frequency Questionnaires in Estimating Food Nutrient Intake in Healthy Young Adults

Healthy Subject

United States
Whanin Pharmaceutical Company

Completed

Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets

Healthy Subject

Korea, Republic of
NovoBliss Research Pvt Ltd

Completed

Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of Products

Healthy Subject

India
Hutchison Medipharma Limited

Completed

A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers

Healthy Subject

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Text Messages in Preventing Tobacco Use in Young Adults

Healthy Subject

United States
University Hospital, Lille

Unknown

Role of the Posterior Parietal Cortex in the Processing of Sensory Information (CORTEX)

Healthy Subject

France
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil （XZP-5849）in Chinese Healthy Adult Male Subjects

Healthy Subject

China
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects

Healthy Subject
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

mHealth Intervention in Increasing HPV Vaccinations in College Students

Healthy Subject

United States
Hospices Civils de Lyon

Completed

Investigation of Docosahexaenoic Acid (DHA) Metabolic Pathway in Human by Using 13C Labeled Molecules (AceDoPC)

Healthy Subject

France
Sensimed AG

Completed

24-hour IOP Pattern With SENSIMED Triggerfish® in a Healthy Population

Healthy Subject

Israel
University of California, Davis
National Institute for Biomedical Imaging and Bioengineering (NIBIB)

Suspended

Single-tracer Multiparametric PET Imaging

Cardiovascular Disease | Healthy Subjects

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study in Healthy Male Subjects to Investigate Whether Administration of Rifampicin Can Affect the Fate of Clazosentan in the Body of Clazosentan

Healthy Subjects

Netherlands
Azienda Ospedaliera Specializzata in Gastroenterologia...

Completed

Glycemic Index of Traditional Egg Pasta

Healthy Subjects | Glycemic Response | Insulinemic Response

Italy
ASLAN Pharmaceuticals

Completed

A Phase 1, 2-Part Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Doses of ASLAN003 in Healthy Elderly Subjects

Healthy Elderly Subjects (Age ≥55 Years)

Singapore
Medical University of Vienna

Completed

Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans

Healthy Subjects | Imparied Retinal Vascular Reactivity

Austria
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Healthy Subjects | Drug-Drug Interaction (DDI)

France
Daniel Doberer

Completed

Effects of Heme Arginate in Healthy Male Subjects (HEMAHS)

Healthy Subjects | Genetic Polymorphism | Heme Oxygenase

Austria
Sensimed AG

Completed

SENSIMED Triggerfish® in Sitting and Supine Position

Healthy Subjects

Israel
Nantes University Hospital

Completed

"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study" (Citrugrêle)

Healthy Subjects

France
Jun Zhu
Nanjing Legend Biotech Co.

Recruiting

Collection of PBMCs From Healthy Subjects for the Development of Cellular Immunotherapy Product

Healthy Subject

China
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Terminated

A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects

Healthy Subject

China
Daewoong Pharmaceutical Co. LTD.

Completed

An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers

Healthy Subject

Korea, Democratic People's Republic of
Beijing InnoCare Pharma Tech Co., Ltd.

Active, not recruiting

Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects

Healthy Subject

China
3D Medicines

Completed

Phase 1 Study of 3D229 in Healthy Subjects

Healthy Subject

China
Aptorum International Limited

Completed

A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers

Healthy Subject

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths

Healthy Subject

United States
Fred Hutchinson Cancer Center
Breast Cancer Research Foundation

Completed

Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants

Healthy Subject

United States
Naturex SA
Biofortis Mérieux NutriSciences

Completed

Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts (KING)

Healthy Subject

France
Jerod L Stapleton, PhD
National Cancer Institute (NCI)

Completed

Behavioral Intervention in Reducing Indoor Tanning

Healthy Subject

United States
National Cancer Institute (NCI)

Completed

Internet-Based and Self-Reports in Assessing Diet and Physical Activity Within AARP

Healthy Subject

United States
Hanlim Pharm. Co., Ltd.

Completed

A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of HL217 Eye Drop in Healthy Male Subjects

Healthy Subject
Betta Pharmaceuticals Co., Ltd.

Unknown

Dose Escalating Study of BPI-3016 in Healthy Subjects

Healthy Subject

China
Hua Medicine Limited

Completed

Human Mass Balance Study of HMS5552 in Healthy Subjects

Healthy Subject

United States
Sihuan Pharmaceutical Holdings Group Ltd.

Completed

Single-dose PK Study of Benapenem In Healthy Subjects

Healthy Subject
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Mobile Health Intervention in Increasing HPV Vaccine Coverage Among Young Adult Gay and Bisexual Men

Healthy Subject

United States
National Cancer Institute (NCI)

Completed

Retinoid 9cUAB30 in Preventing Cancer in Healthy Volunteers

Healthy Subject

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

HPV Vaccine Intervention for Young Sexual Minority Men

Healthy Subject

United States
Changchun GeneScience Pharmaceutical Co., Ltd.

Completed

To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.

Healthy Subject

China
Celltrion

Completed

Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects

Healthy Subject

Korea, Republic of
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
GeneScience Pharmaceuticals Co., Ltd.

Completed

GS3-007a Oral Solution in Healthy Subjects

Healthy Subject

China
Kyowa Kirin Co., Ltd.

Completed

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

Healthy Subject

Japan
Yiling Pharmaceutical Inc.

Completed

A Phase I Pharmacokinetics Study for KT07 Capsule

Pharmacokinetics | Healthy Adult Subjects | Safety and Tolerability

United States
Daiichi Sankyo Co., Ltd.

Completed

A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants

Healthy Subjects | Pharmacokinetics | Drug-drug Interaction | Quizartinib

United States
University Hospital Tuebingen
Institute of Ophthalmic Research Tuebingen; Institute for Clinical Epidemiology...

Unknown

Metabolites of Tear Fluid (Metabol-T)

Healthy Subjects

Germany
Astellas Pharma Europe B.V.

Completed

Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male Subjects

Healthy Subjects | Pharmacokinetics | Drug-Drug Interaction (DDI)

Germany
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and Tolerability

Healthy Subjects | Pharmacokinetics | Pharmacodynamics | Effect of Race

United Kingdom
Astellas Pharma Inc

Completed

Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers

Healthy Subjects | Drug Interactions | Pharmacokinetics of ASP015K

United States
Central Hospital, Nancy, France

Recruiting

Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam (AIMANT)

Healthy Subjects | Patient Performing an MRI Examination

France

Clinical Trials on Healthy Chinese Subjects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations